|
NR1D2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.48809999999966E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.16159999963683E-07 |
| Normal-vs-Stage2 |
1.799260E-03 |
| Normal-vs-Stage3 |
6.562000E-04 |
| Normal-vs-Stage4 |
4.19160000000307E-05 |
| Stage1-vs-Stage2 |
8.225200E-01 |
| Stage1-vs-Stage3 |
7.395000E-01 |
| Stage1-vs-Stage4 |
1.322750E-01 |
| Stage2-vs-Stage3 |
6.913400E-01 |
| Stage2-vs-Stage4 |
1.493840E-01 |
| Stage3-vs-Stage4 |
2.346600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.407190E-04 |
| Normal-vs-AfricanAmerican |
9.88149999999743E-05 |
| Normal-vs-Asian |
2.515700E-03 |
| Caucasian-vs-AfricanAmerican |
6.704200E-01 |
| Caucasian-vs-Asian |
4.003400E-01 |
| AfricanAmerican-vs-Asian |
2.118800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90827999999588E-05 |
| Normal-vs-Female |
2.963000E-03 |
| Male-vs-Female |
1.951220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.97180000000219E-05 |
| Normal-vs-Extreme_Weight |
4.19780000000536E-05 |
| Normal-vs-Obese |
6.372000E-04 |
| Normal-vs-Extreme_Obese |
2.433000E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.271400E-01 |
| Normal_Weight-vs-Obese |
2.736600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.138200E-01 |
| Extreme_Weight-vs-Obese |
3.925400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.729800E-01 |
| Obese-vs-Extreme_Obese |
1.895790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.383700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.961850E-03 |
| Normal-vs-Age(61-80Yrs) |
4.20690000002555E-06 |
| Normal-vs-Age(81-100Yrs) |
6.241000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.722800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.547650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.890610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.038000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.326400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.023800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.53419999999428E-05 |
| Normal-VS-Type2 PRCC |
5.78680003915366E-09 |
| Normal-VS-KIRP CIMP |
1.815850E-02 |
| Normal-VS-Unclassified PRCC |
2.360000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.678100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.807800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.584600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.480970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.793800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.202800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.07650005260518E-09 |
| Normal-vs-N1 |
8.010200E-04 |
| Normal-vs-N2 |
6.184800E-03 |
| N0-vs-N1 |
4.159200E-01 |
| N0-vs-N2 |
6.520200E-01 |
| N1-vs-N2 |
5.161200E-01 |
|
|
